Securities Code: 002118
Securities Abbreviation: *ST Zixin
Announcement Number: 2023-079
Jilin Zixin Pharmaceutical Co., Ltd. announces that the company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- According to Article 9.2.1 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," as of June 12, 2023, the company's stock closing price was 0.43 CNY/share, and the stock price has been below 1 CNY for 17 consecutive trading days. Even if the stock experiences a limit-up for the next three trading days, it will still trigger the delisting criteria due to the stock price being below 1 CNY for 20 consecutive trading days. If this occurs, the Shenzhen Stock Exchange will make a decision to terminate the listing of the company's stock within the stipulated time frame, and the stock will not enter a delisting adjustment period.
- According to Article 9.2.3 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the company must disclose the risk warning regarding the possible termination of listing due to the stock price being below par value. This warning will be disclosed daily until the relevant situation is resolved or until the Shenzhen Stock Exchange makes a decision to terminate the listing of the company's stock. Investors are advised to invest rationally and pay attention to risks.